.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Dow
Baxter
Argus Health
Federal Trade Commission
Covington
Queensland Health
Daiichi Sankyo
Cipla
UBS

Generated: January 17, 2018

DrugPatentWatch Database Preview

Patents Expiring in August 2028

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Ipsen IncONIVYDEirinotecan hydrochlorideINJECTABLE, LIPOSOMAL;IV (INFUSION)207793-001Oct 22, 2015RXYesYes➤ Subscribe➤ SubscribeYY
Opko Ireland GlobalRAYALDEEcalcifediolCAPSULE, EXTENDED RELEASE;ORAL208010-001Jun 17, 2016RXYesYes➤ Subscribe➤ SubscribeYUSE OF SUSTAINED RELEASE 25-HYDROXYVITAMIN D IN TREATING PATIENTS HAVING 25-HYDROXYVITAMIN D INSUFFICIENCY OR DEFICIENCY
Corcept TherapKORLYMmifepristoneTABLET;ORAL202107-001Feb 17, 2012RXYesYes➤ Subscribe➤ SubscribeTREATING CUSHING'S SYNDROME
NovartisTASIGNAnilotinib hydrochloride monohydrateCAPSULE;ORAL022068-001Oct 29, 2007RXYesYes➤ Subscribe➤ SubscribeYY
NovartisTASIGNAnilotinib hydrochloride monohydrateCAPSULE;ORAL022068-002Jun 17, 2010RXYesNo➤ Subscribe➤ SubscribeYY
Astrazeneca AbBYDUREON PENexenatide syntheticFOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200-002Feb 28, 2014RXYesYes➤ Subscribe➤ SubscribeY
Astrazeneca AbFARXIGAdapagliflozin propanediolTABLET;ORAL202293-002Jan 8, 2014RXYesYes➤ Subscribe➤ SubscribeY
Astrazeneca AbFARXIGAdapagliflozin propanediolTABLET;ORAL202293-001Jan 8, 2014RXYesNo➤ Subscribe➤ SubscribeY
Daiichi Sankyo IncMORPHABOND ERmorphine sulfateTABLET, EXTENDED RELEASE;ORAL206544-004Oct 2, 2015RXYesYes➤ Subscribe➤ SubscribeY
Daiichi Sankyo IncMORPHABOND ERmorphine sulfateTABLET, EXTENDED RELEASE;ORAL206544-003Oct 2, 2015RXYesNo➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Novartis
QuintilesIMS
Daiichi Sankyo
Queensland Health
McKinsey
Express Scripts
Cerilliant
Harvard Business School
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot